Visit Toujeo.com for more information.
Recently, we spoke with Jenny Sung, Associate Vice President, Evidence Based Medicine Research at Sanofi US, who was recently honored by the Healthcare Businesswomen’s Association (HBA) as a 2016 Rising Star.
Sanofi US is voluntarily recalling all Auvi-Q® (epinephrine injection, USP). The recall involves all Auvi-Q® currently on the market and includes both the 0.15 mg and 0.3 mg strengths for hospitals, retailers and consumers.
Last update: April 15, 2016